---
title: "Lu AF28996 in Patients With Parkinson's Disease"
euct_id: 2023-507785-12-00
phase: Phase 3
status: Completed
sponsor: H. Lundbeck A/S
canonical_url: "https://parkinsonspathways.com/trials/eu/2023-507785-12-00"
eu_clinical_trials_register: "https://euclinicaltrials.eu/ctis-public/view/2023-507785-12-00"
ctis_last_updated: "2026-02-13T02:34:13.385720172"
source: EU Clinical Trials Information System (CTIS)
---
# Lu AF28996 in Patients With Parkinson's Disease

**EU CT Number:** [2023-507785-12-00](https://euclinicaltrials.eu/ctis-public/view/2023-507785-12-00)

## Key Facts

- **Phase:** Phase 3
- **Status:** Completed
- **Sponsor:** H. Lundbeck A/S
- **Start Date:** 2024-05-17
- **Completion Date:** 2025-09-10
- **Conditions:** Parkinson's Disease

## Member States

Trial is authorized in 3 member states: France, Germany, Spain.

## Sites (5)

- Centre Hospitalier Universitaire De Caen Normandie, Caen Cedex 9, France
- Hospital Universitari Vall D Hebron, Barcelona, Spain
- University Hospital Virgen Del Rocio S.L., Sevilla, Spain
- Hospital Universitari General De Catalunya, Sant Cugat Del Valles, Spain
- curiositas ad sanum Studien und Beratungs GmbH, Ebersberg, Germany

## Eligibility (CTIS)

- **Minimum age:** 18 Years
- **Sex:** ALL

```
Condition: Parkinson's Disease
Age groups: elderly 65+, adults 18-64
Sex: male, female
```

---

*Canonical: https://parkinsonspathways.com/trials/eu/2023-507785-12-00*  
*HTML version: https://parkinsonspathways.com/trials/eu/2023-507785-12-00*  
*Source data: https://euclinicaltrials.eu/ctis-public/view/2023-507785-12-00*